-
Shared Decision Making in Inflammatory Bowel Disease: An Observational Study Combining Patient Physician and Observer Perspectives
Sep 9, 2025, 16:22 PM -
Predicting the Maximum Fair Price (MFP) From Medicare Negotiations
Sep 9, 2025, 16:22 PM -
Primary Expenditure Drivers and Future Challenges From Emerging Technologies in Brazilian Private Market Real-World Data Analysis From a Brazilian Employer-Sponsored, Self-Insured Health Plan
Sep 9, 2025, 16:22 PM -
Patient Pathways to Accessing Unregistered Medicines in Low-Priority Launch Markets
Sep 9, 2025, 16:22 PM -
Trends and Scope of Japan’s Across-the-Board Pharmaceutical Price Revisions in FY2021-25
Sep 9, 2025, 16:22 PM -
Comprehensive Landscape Assessment of Real-World Databases for HEOR Studies in the Asia-Pacific Region: A Growing Opportunity
Sep 9, 2025, 16:22 PM -
A Comparison of the NICE HST Program With Health Technology Assessments of Ultra-Orphan Drugs From France and Germany
Sep 9, 2025, 16:22 PM -
Hidden Obesity and Treatment Gaps in Japan: A Real-World Data Analysis
Sep 9, 2025, 16:22 PM -
Regulatory Approval and Economic Evaluation of Tumor-Agnostic Therapies: A Comparative Study of Larotrectinib and Entrectinib
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Gemcitabine Nabpaclitaxel Combination, Modified FOLFIRINOX, and SIROX As First-Line Therapy for Pancreatic Cancer
Sep 9, 2025, 16:22 PM -
Gaps in Evidence on Burden and HRQoL in Small-Cell Lung Cancer: Findings From a Targeted Literature Review
Sep 9, 2025, 16:22 PM -
Prediction of Query Outcomes in the Setting of Observational Studies
Sep 9, 2025, 16:22 PM -
Drivers of Inpatient Costs in Oncology Patients Undergoing Major Abdominal Surgery: Evidence from a Middle-Income Country
Sep 9, 2025, 16:22 PM -
Navigating the MFN Pricing Era: Strategic Imperatives for Biopharma
Sep 9, 2025, 16:22 PM -
Direct Healthcare Costs (HCCs) Inequalities Associated With Myasthenia Gravis (MG) in Hungary: Claims Database Analysis
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis of High-Energy High-Protein (HEHP) Oral Nutritional Support (ONS) for the Treatment of Disease-Related Malnutrition (DRM) in Cancer Patients in the French Community Setting
Sep 9, 2025, 16:22 PM -
Recognizing the Full Value of Novel Antibiotics: Identifying Value Elements in the Context of Antimicrobial Resistance
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis of Eplerenone For the Management of Heart Failure With Reduced Ejection Fraction (HFrEF) in Italy
Sep 9, 2025, 16:22 PM -
Assessing the Real-World Impact of Earlier Initiation of Anti-Tumor Necrosis Factor vs. Conventional Synthetic DMARDs on Clinical and Patient-Reported Outcomes in Patients With Rheumatoid Arthritis in Europe
Sep 9, 2025, 16:22 PM -
Germany: Still a Benchmark for ATMP Access and Pricing: A Pricing Analysis of Germany's ATMP Landscape Compared to Other European Countries
Sep 9, 2025, 16:22 PM
